Hinge Health, Inc.

Hinge Health's RSI of 75.2 signals extreme overbought conditions, yet the stock sits below its 52-week high—a peculiar disconnect suggesting recent momentum without full recovery to prior peaks. Trading at $4.3B market cap with an unavailable P/E ratio (likely unprofitable), HNGE operates in the crowded digital health services space where profitability benchmarks remain elusive. The 7.35% short interest is moderate, reducing squeeze risk, but the elevated RSI combined with absent earnings metrics implies valuation rests entirely on growth narrative rather than fundamentals. This setup carries meaningful pullback risk despite the bullish momentum reading.